HealthStream Announces Fourth Quarter & Full Year 2016 Results

Go back to HealthStream Announces Fourth Quarter & Full Year 2016 Results

Needham & Company Reiterates Buy on HealthStream (HSTM) Following 4Q

February 23, 2017 7:03 AM EST

Needham & Company reiterated a Buy rating and $28.00 price target on HealthStream (NASDAQ: HSTM) following the company's 4Q earnings report. 4Q revenues and EPS of $58.7mm/$0.02 came in below $61.4mm/$0.04 estimates.

Analyst Scott Berg commented, "HSTM reported 4Q revenue/EPS results below our... More

Cantor Fitzgerald Reiterates Neutral Rating and $27 PT on HealthStream (HSTM) Following 'Light' 4Q16 Results

February 22, 2017 6:52 AM EST

Cantor Fitzgerald analyst Steven Halper reiterates Neutral rating and $27 price target on HealthStream Inc. (NASDAQ: HSTM), as the company offered solid 2017 revenue guidance, offsetting 2016 fourth quarter results that were below consensus estimates.

Halper comments, "After the close on Tuesday, February 21, HealthStream reported 4Q16... More

HealthStream (HSTM) Misses Q4 EPS by 5c

February 21, 2017 4:32 PM EST

HealthStream (NASDAQ: HSTM) reported Q4 EPS of ($0.01), $0.05 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $58.7 million versus the consensus estimate of $60.67 million.

For earnings history and earnings-related data on HealthStream (HSTM) click here.

... More